Oxford BioDynamics revenue up 49% in first half as test sales rise
18th Jun 2024 16:58
(Alliance News) - Oxford BioDynamics PLC on Tuesday reported strong revenue growth on the back of the increased commercialisation of its EpiSwitch genomics platform. Read More